Therapies on the horizon for cholesterol reductionBROWN, W. Virgil.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.24-III.27, SUP3Article

Cholesterol absorption inhibitors: Defining new options in lipid managementBROWN, W. Virgil.Clinical cardiology (Mahwah, NJ). 2003, Vol 26, Num 6, pp 259-264, issn 0160-9289, 6 p.Article

Epidemiology and treatment of hypercholesterolemia: Where we are todayBROWN, W. Virgil.The American journal of medicine. 1997, Vol 102, Num 2A, issn 0002-9343, 58 p.Serial Issue

What are the priorities for managing cholesterol effectively?BROWN, W. Virgil.The American journal of cardiology. 2001, Vol 88, Num 4A, pp 21F-24F, issn 0002-9149Article

Statin therapy in the new millennium: is there room for improvement?BROWN, W. Virgil.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, 29 p., SUP3Serial Issue

How do we achieve optimal cardiovascular risk reduction?GOTTO, Antonio M.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.8-III.12, SUP3Article

Management of high serum cholesterol and related disorders in patients at risk for coronary heart diseaseGRUNDY, S. M.The American journal of medicine. 1997, Vol 102, Num 2A, pp 15-22, issn 0002-9343Article

Updated clinical safety experience with fluvastatinJOKUBAITIS, L. A.The American journal of cardiology. 1994, Vol 73, Num 14, pp 18D-24D, issn 0002-9149Article

Microvascular Complications of Diabetes Mellitus : Renal Protection Accompanies Cardiovascular ProtectionBROWN, W. Virgil.The American journal of cardiology. 2008, Vol 102, Num 12, issn 0002-9149, 10L-13L, SUPArticle

A new statin : A new standardOLSSON, Anders G.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.18-III.23, SUP3Article

Cholesterol screening should be targetedGARBER, A. M.The American journal of medicine. 1997, Vol 102, Num 2A, pp 26-30, issn 0002-9343Article

What do the statin trials tell us?WATERS, David D.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.3-III.7, SUP3Article

A population-based approach to cholesterol controlCOHEN, J. D.The American journal of medicine. 1997, Vol 102, Num 2A, pp 23-25, issn 0002-9343Article

Clinical implications of the biopharmaceutical properties of fluvastatinDESLYPERE, J.-P.The American journal of cardiology. 1994, Vol 73, Num 14, pp 12D-17D, issn 0002-9149Article

Newer risk markers and surrogate endpoints in atherosclerosis managementBALLANTYNE, Christie M.Clinical cardiology. Supplement (Mahwah, NJ). 2001, Vol 24, Num 8, pp III.13-III.17, SUP3Article

Cholesterol lowering in atherosclerosisBROWN, W. Virgil; MD.The American journal of cardiology. 2000, Vol 86, Num 4B, pp 29H-32H, issn 0002-9149Article

Hypercholesterolemia in the United States : How far have we come?BROWN, W. V.The American journal of medicine. 1997, Vol 102, Num 2A, pp 3-6, issn 0002-9343Article

Nonlipoprotein risk factors for coronary heart disease : Evaluation and managementPARMLEY, W. W.The American journal of medicine. 1997, Vol 102, Num 2A, pp 7-14, issn 0002-9343Article

Adults aged 20 and older should have their cholesterol measuredCLEEMAN, J. I.The American journal of medicine. 1997, Vol 102, Num 2A, pp 31-36, issn 0002-9343Article

Benefits of stain therapy in patients with special risks: Coronary bypass surgery, stable coronary disease, and acute coronary syndromesBROWN, W. Virgil.Clinical cardiology. Supplement (Mahwah, NJ). 2003, Vol 26, Num 3, pp III.13-III18Conference Paper

Current status of cholesterol treatment in the community : The Minnesota Heart SurveyLUEPKER, R. V.The American journal of medicine. 1997, Vol 102, Num 2A, pp 37-42, issn 0002-9343Article

Compliance with treatment regimens in chronic asymptomatic diseasesMILLER, N. H.The American journal of medicine. 1997, Vol 102, Num 2A, pp 43-49, issn 0002-9343Article

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductaseBLUM, C. B.The American journal of cardiology. 1994, Vol 73, Num 14, pp 3D-11D, issn 0002-9149Article

Evidence for the in vivo generation of oxidatively modified epitopes in patients with atherosclerotic endotheliumLE, Ngoc-Anh; XIANZHOU LI; SUNG KYUNG et al.Metabolism, clinical and experimental. 2000, Vol 49, Num 10, pp 1271-1277, issn 0026-0495Article

Combination therapy with fluvastatin and niacin in hypercholesterolemia : a preliminary report on safetyJACOBSON, T. A; AMOROSA, L. F.The American journal of cardiology. 1994, Vol 73, Num 14, pp 25D-29D, issn 0002-9149Article